319 Biocolloids, Biomolecules, and Nanomaterials of Medical Relevance


Description:
The study of colloidal phenomena has been recently associated with microorganisms and provide new insights on cell assembly at fluid interfaces. Cells can produce biomolecules, be controlled by colloidal particles, or be assimilated to biocolloids. The size, composition of the particles interacting with cells in various contexts (e.g. bioremediation, dental health) accounts for the selections of the biocolloids. This session presents advances made to sequester colloids from or with cells, and to generate nanomaterials that can alleviate the deleterious effects of pathogens.

Sponsor:
Microbes at Biomedical Interfaces
Co-Sponsor(s):
Interfacial Phenomena (01C), Transport Processes (01D), Bioengineering (15C), Biomaterials (08B), Bionanotechnology (22B)


Chair:
Nancy J. Lin
Research Associate
NIST
100 Bureau Drive
Gaithersburg, MD
20899
Email: nancy.lin@nist.gov

Co-Chair:
Jacinta Conrad
University of Houston
Chemical & Biomolecular Engineering
Houston, TX
77204
Email: jcconrad@uh.edu


Papers:
319a
Mechanisms Contributing to the Formation of "Floating Biofilms" in Staphylococcus Aureus Orthopedic Infections (Invited Talk)
Michael Otto, The National Institutes of Health
319b
Bacteria Adhesion Is Mechanosensitive to Polymer Coating Properties (Invited Talk)
Jessica Schiffman, University of Massachusetts Amherst
319c
Invited Talk 3: Prospective Technologies Targeting Microbial Biofilm and Its Microenvironment
Hyun Koo, University of Pennsylvania
319d
Investigating the Interfacial and Metabolic Properties of Bacteria at Hexadecane-Water Interfaces
Nicholas Waters, University of Pittsburgh; Sricharani Balmuri, University of Pittsburgh; Tagbo H.R. Niepa, University of Pittsburgh
319e
Complex Liquid Emulsions and on-Chip Ring Resonators for Bacteria Detection
Suchol Savagatrup, Massachusetts Institute of Technology; Timothy M. Swager, Massachusetts Institute of Technology
319f
Native Airway Mucus Rheology in Health and Patients with Cystic Fibrosis Having Positive or Negative Microbial Culture
Matthew R. Markovetz, University of North Carolina; Marianne Muhlebach, University of North Carolina; Ian Garbarine, University of North Carolina; Charles R. Esther, University of North Carolina; Richard C. Boucher, University of North Carolina; David B. Hill, University of North Carolina
319g
Engineering Biology to Make Novel Antimicrobials
Cesar de la Fuente-Nunez, MIT
319h
Association with Outer Membrane Vesicles Drastically Alters Bacterial Toxin Activity
Angela C. Brown, Lehigh University; Elnaz S. Rasti, Lehigh University; Justin Nice, Lehigh University; Shannon Collins, Lehigh University
Abstract Submissions Closed
See more of this Group/Topical: Topical Conference: Microbes at Biomedical Interfaces
<< Previous Session | Next Session >>